NBRV insider filings
Nabriva Therapeutics plc — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-01-31. Screen NBRV transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for NBRV between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — Nabriva Therapeutics plc
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2023-01-31 | 4 | Gelone Steven P. — Director | Tax withholding (F): 140 @ $1.50 | EDGAR |
| 2023-01-31 | 4 | Schroeder Theodore R — Director | Tax withholding (F): 431 @ $1.50 | EDGAR |
| 2023-01-10 | 4 | Gelone Steven P. — President and COO, Director | Tax withholding (F): 5 @ $1.30 | EDGAR |
| 2023-01-10 | 4 | Schroeder Theodore R — Chief Executive Officer, Director | Tax withholding (F): 11 @ $1.30 | EDGAR |
| 2023-01-04 | 4 | Gelone Steven P. — President and COO, Director | Tax withholding (F): 3 @ $1.89 | EDGAR |
| 2023-01-04 | 4 | Schroeder Theodore R — Chief Executive Officer, Director | Tax withholding (F): 5 @ $1.89 | EDGAR |
| 2022-12-08 | 4 | Gelone Steven P. — President and COO, Director | Tax withholding (F): 4 @ $2.02 | EDGAR |
| 2022-12-08 | 4 | Schroeder Theodore R — Chief Executive Officer, Director | Tax withholding (F): 9 @ $2.02 | EDGAR |
| 2022-12-02 | 4 | Gelone Steven P. — President and COO, Director | Tax withholding (F): 3 @ $2.25 | EDGAR |
| 2022-12-02 | 4 | Schroeder Theodore R — Chief Executive Officer, Director | Tax withholding (F): 5 @ $2.25 | EDGAR |
| 2022-11-08 | 4 | Gelone Steven P. — President and COO, Director | Tax withholding (F): 4 @ $2.24 | EDGAR |
| 2022-11-08 | 4 | Schroeder Theodore R — Chief Executive Officer, Director | Tax withholding (F): 10 @ $2.24 | EDGAR |
| 2022-11-01 | 4 | Gelone Steven P. — President and COO, Director | Tax withholding (F): 3 @ $2.54 | EDGAR |
| 2022-11-01 | 4 | Schroeder Theodore R — Chief Executive Officer, Director | Tax withholding (F): 5 @ $2.54 | EDGAR |
| 2022-10-11 | 4 | Gelone Steven P. — President and COO, Director | Tax withholding (F): 4 @ $2.72 | EDGAR |
| 2022-10-11 | 4 | Schroeder Theodore R — Chief Executive Officer, Director | Tax withholding (F): 9 @ $2.72 | EDGAR |
| 2022-10-04 | 4 | Gelone Steven P. — President and COO, Director | Tax withholding (F): 3 @ $2.08 | EDGAR |
| 2022-10-04 | 4 | Schroeder Theodore R — Chief Executive Officer, Director | Tax withholding (F): 5 @ $2.08 | EDGAR |
| 2022-09-07 | 4 | Gelone Steven P. — President and COO, Director | Tax withholding (F): 89 @ $0.16 | EDGAR |
| 2022-09-07 | 4 | Schroeder Theodore R — Chief Executive Officer, Director | Tax withholding (F): 225 @ $0.16 | EDGAR |
| 2022-09-01 | 4 | Gelone Steven P. — President and COO, Director | Tax withholding (F): 61 @ $0.16 | EDGAR |
| 2022-09-01 | 4 | Schroeder Theodore R — Chief Executive Officer, Director | Tax withholding (F): 107 @ $0.16 | EDGAR |
| 2022-08-15 | 4 | Gelone Steven P. — President and COO, Director | Option exercise (M): 93,400 (derivative) @ $0 · Option exercise (M): 46,700 (derivative) @ $0 · Option exercise (M): 93,400 (derivative) @ $0 · Option exercise (M): 46,700 (derivative) @ $0 | EDGAR |
| 2022-08-15 | 4 | Dolan Daniel — Chief Financial Officer | Option exercise (M): 83,200 (derivative) @ $0 · Option exercise (M): 41,600 (derivative) @ $0 · Option exercise (M): 83,200 (derivative) @ $0 · Option exercise (M): 41,600 (derivative) @ $0 | EDGAR |
| 2022-08-15 | 4 | Guico-Pabia Christine J. — Chief Medical Officer | Option exercise (M): 71,500 (derivative) @ $0 · Option exercise (M): 35,700 (derivative) @ $0 · Option exercise (M): 71,500 (derivative) @ $0 · Option exercise (M): 35,700 (derivative) @ $0 | EDGAR |
| 2022-08-15 | 4 | Naftzger J. Christopher — General Counsel and Corp Sec | Option exercise (M): 63,200 (derivative) @ $0 · Option exercise (M): 31,600 (derivative) @ $0 · Option exercise (M): 63,200 (derivative) @ $0 · Option exercise (M): 31,600 (derivative) @ $0 | EDGAR |
| 2022-08-15 | 4 | Schroeder Theodore R — Chief Executive Officer, Director | Option exercise (M): 239,800 (derivative) @ $0 · Option exercise (M): 119,900 (derivative) @ $0 · Option exercise (M): 239,800 (derivative) @ $0 · Option exercise (M): 119,900 (derivative) @ $0 | EDGAR |
| 2022-08-08 | 4 | Gelone Steven P. — President and COO, Director | Tax withholding (F): 89 @ $0.18 | EDGAR |
| 2022-08-08 | 4 | Schroeder Theodore R — Chief Executive Officer, Director | Tax withholding (F): 225 @ $0.18 | EDGAR |
| 2022-08-04 | 4 | Webster Stephen W — Director | Sale (S): 7,826 @ $0.19 | EDGAR |
| 2022-08-04 | 4 | Broom Colin MD — Director | Sale (S): 5,339 @ $0.19 | EDGAR |
| 2022-08-04 | 4 | CORRIGAN MARK — Director | Sale (S): 10,297 @ $0.19 | EDGAR |
| 2022-08-04 | 4 | BURGESS DANIEL D — Director | Sale (S): 11,341 @ $0.19 | EDGAR |
| 2022-08-03 | 4 | Dalton Lisa — Director | Tax withholding (F): 8,400 @ $0.18 | EDGAR |
| 2022-08-03 | 4 | Gelone Steven P. — President and COO, Director | Tax withholding (F): 61 @ $0.18 | EDGAR |
| 2022-08-03 | 4 | Bourdow Carrie L. — Director | Sale (S): 8,540 @ $0.17 | EDGAR |
| 2022-08-03 | 4 | Rowland Charles A Jr — Director | Sale (S): 8,496 @ $0.17 | EDGAR |
| 2022-08-03 | 4 | Schroeder Theodore R — Chief Executive Officer, Director | Tax withholding (F): 107 @ $0.18 | EDGAR |
| 2022-07-07 | 4 | Gelone Steven P. — President and COO, Director | Tax withholding (F): 89 @ $0.18 | EDGAR |
| 2022-07-07 | 4 | Schroeder Theodore R — Chief Executive Officer, Director | Tax withholding (F): 225 @ $0.18 | EDGAR |
| 2022-07-01 | 4 | Gelone Steven P. — President and COO, Director | Tax withholding (F): 61 @ $0.18 | EDGAR |
| 2022-07-01 | 4 | Schroeder Theodore R — Chief Executive Officer, Director | Tax withholding (F): 107 @ $0.18 | EDGAR |
| 2022-06-07 | 4 | Gelone Steven P. — President and COO, Director | Tax withholding (F): 89 @ $0.20 | EDGAR |
| 2022-06-07 | 4 | Schroeder Theodore R — Chief Executive Officer, Director | Tax withholding (F): 225 @ $0.20 | EDGAR |
| 2022-06-02 | 4 | Gelone Steven P. — President and COO, Director | Tax withholding (F): 61 @ $0.21 | EDGAR |
| 2022-06-02 | 4 | Schroeder Theodore R — Chief Executive Officer, Director | Tax withholding (F): 107 @ $0.21 | EDGAR |
| 2022-05-09 | 4 | Gelone Steven P. — President and COO, Director | Tax withholding (F): 89 @ $0.26 | EDGAR |
| 2022-05-09 | 4 | Schroeder Theodore R — Chief Executive Officer, Director | Tax withholding (F): 225 @ $0.26 | EDGAR |
| 2022-05-03 | 4 | Gelone Steven P. — President and COO, Director | Tax withholding (F): 61 @ $0.31 | EDGAR |
| 2022-05-03 | 4 | Schroeder Theodore R — Chief Executive Officer, Director | Tax withholding (F): 107 @ $0.31 | EDGAR |
Recent 8-K events — Nabriva Therapeutics plc
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2023-07-31 | 8-K | 1.01 — Entry into a Material Definitive Agreement 1.02 — Termination of a Material Definitive Agreement 2.01 — Completion of Acquisition or Disposition of Assets 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-07-24 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2023-07-07 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-06-01 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2023-02-06 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-01-20 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-01-09 | 8-K | 1.02 — Termination of a Material Definitive Agreement ? 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-11-28 | 8-K | 8.01 — Other Events | EDGAR |
| 2022-11-10 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-10-04 | 8-K | 8.01 — Other Events | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=NBRV returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs